Skip to main content

Artificial intelligence related hiring is on the rise

Written on .

Artificial intelligence is the key disruptive force facing the pharmaceutical industry in coming years.

This is evident in the sheer number of AI related positions that are being advertised across the world. Analysis by GlobalData, found that 37.4% of companies surveyed were recruiting for at least one AI related position.

This raises questions and concerns about job security, but the increasing prevalence of AI brings with it new opportunities for new skills.

Upskilling and reskilling

As AI increases in capability and use, so will the demand for professionals who can develop, integrate, and maintain AI technologies. Specialized roles such as AI scientists, data analysts, and machine learning engineers will become increasingly necessary. There will also be a need for skills in managing the ethical and regulatory aspects of AI implementation, to overcome concerns around accuracy, safety and data security.

Collaboration between AI and human experts will always be the key to leveraging the benefits of AI.

While some may feel their job is threatened by AI, it is worth remembering that while some roles will be altered, others will be created. It is crucial that companies invest in upskilling and reskilling their workforce to avoid falling behind and unlock the full potential of AI.

Companies already using AI to improve their processes

In the pharma industry AI has the potential to drastically improve manufacturing, drug discovery, diagnostics, precision medicine, personalized treatment, clinical trials and the list goes on.

One example is British healthcare technology company Medopad teamed up with Chinese tech giant Tencent to train AI to detect Parkinson’s Disease within 3 minutes.

Sony has been working on an AI-driven imaging collaboration system called NUCLeUS for surgery, enhancing precision and safety. 

Closer to home, Japanese pharmaceutical company Eisai has been trying to speed up the trial and error process of finding small molecule compounds by utilizing AI technologies such as machine learning and deep learning.

The surge in AI-related jobs reveals the changing landscape and trend towards exploring the opportunities presented by AI. Companies that invest in AI now will undoubtedly be better equipped for the future of business and pharmaceuticals. 

To build a team that is equipped for the future, book a discovery session with Morunda. 

Share This Post